Combination therapy of IL-2 and DTIC for the treatment of melano

Details Combination therapy of IL-2 and DTIC for the treatment of melano Combination therapy of IL-2 and DTIC for the treatment of melano

1988-03-28

1991-03-12

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 8, 514 12, 514398, 424 852, A61K 3700, A61K 31415, A61K 3900, A61K 4502

Patent

active

049993399

ABSTRACT:
Therapeutic treatment of malignant melanoma in humans is disclosed wherein a synergistically effective amount of DTIC in combination with IL-2 is administered to an individual having such cancer.

REFERENCES:
patent: 4518584 (1985-05-01), Mark et al.
Dorr et al. Cancer Chemotherapy Handbook, pp. 362-367, 1980 by Elsevier North Holland, Inc. Third Printing (1981).
Roth et al. Current Concepts of Oncology, vol. 9(5):2-11.
Rosenberg et al. The New England Journal of Medicine, vol. 316(15):889-897 (1987).
Salup et al. Cancer Research, vol. 46:3358-3363 (1986).
DeVita et al. Cancer Principles & Practice of Oncology, 2nd Edition J. B. Lippincott Company (1985) pp. 1405-1408.
Creagan et al. Cancer Treatment Rep, vol. 70(5):619-624 (1986).
Roth et al. J Immunol., vol. 130:303-308 (1983).
Mule et al. Science, vol. 225:1487-1489 (1984).
Cancer Rates and Risks, 3rd Edition (1985) NIH Publishing No. 85-691:99-101.
Thurman et al., (1986) J Biol Resp Modifiers 5:85-107.
Legha (1989) Seminars in Oncology 16 (1):34-44.
Stoter et al. Eur J Cancer Clin Oncol 25:Supp 3, pp. 541-544 (1989).
Shiloni et al. Eur J Cancer Clin Oncol, vol. 25:Supp 3, pp. 545-549 (1989).

Affiliated with

Also associated with

Rating

Combination therapy of IL-2 and DTIC for the treatment of melano does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy of IL-2 and DTIC for the treatment of melano, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy of IL-2 and DTIC for the treatment of melano will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-448629